readthroughSign in
CompanyCCCCNasdaqWatertown, MA

C4 Therapeutics, Inc.

C4 Therapeutics develops small-molecule protein degraders using its TORPEDO platform.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story